GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Uniphar PLC (FRA:0NR) » Definitions » Debt-to-Revenue

Uniphar (FRA:0NR) Debt-to-Revenue : 0.15 (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Uniphar Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Uniphar's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €32 Mil. Uniphar's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €374 Mil. Uniphar's annualized Revenue for the quarter that ended in Dec. 2024 was €2,806 Mil. Uniphar's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 0.14.


Uniphar Debt-to-Revenue Historical Data

The historical data trend for Uniphar's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Uniphar Debt-to-Revenue Chart

Uniphar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only 0.12 0.13 0.15 0.15 0.15

Uniphar Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.15 0.15 0.15 0.15

Competitive Comparison of Uniphar's Debt-to-Revenue

For the Medical Distribution subindustry, Uniphar's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Uniphar's Debt-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Uniphar's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Uniphar's Debt-to-Revenue falls into.



Uniphar Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Uniphar's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(31.896 + 374.258) / 2770.429
=0.15

Uniphar's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(31.896 + 374.258) / 2805.702
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2024) Revenue data.


Uniphar Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Uniphar's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Uniphar Business Description

Traded in Other Exchanges
Address
4045 Kingswood Road, Citywest Business Park, Dublin, IRL, D24 V06K
Uniphar PLC is a diversified healthcare service organization with activities in Ireland, the UK, and the Benelux. The business activities of the group function through the Commercial & Clinical division, which provides outsourced services, specifically sales, marketing, and multichannel account management to pharmaco-medical manufacturers, and distribution and support services to medical device manufacturers. The product Access division consists of two service offerings, being: On-Demand Access and Exclusive Access. Supply Chain & Retail division provides both pre-wholesale distribution and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and vEterinary surgeons in Ireland.

Uniphar Headlines

No Headlines